In BRG1-overexpressing breast cancer cells, knockdown of BRG1 suppresses expression of lipogenesis genes and moderately sensitizes them to fatty acid synthesis inhibition (Wu et al. 2016). This evidence concerns the gene SMARCA4 and breast carcinoma.